Irinotecan and docetaxel as first line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer - experience from a prematurely closed phase II study

被引：8
|
作者：
Raez, LE [1 ]
Rosado, MF [1 ]
Santos, ES [1 ]
Reis, IM [1 ]
机构：
[1] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Div Hematol Oncol, Miami, FL 33136 USA
来源：
LUNG CANCER | 2004年 / 45卷 / 01期
关键词：
D O I：
10.1016/j.lungcan.2004.01.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：131 / 132
页数：2
相关论文
共 50 条
  • [41] Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer
    Younes, Riad Naim
    Pereira, Jost Rodrigues
    Fares, Abdo Latif
    Gross, Jefferson Luiz
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2011, 57 (06): : 686 - 691
  • [42] A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer
    Bennouna, J
    Monnier, A
    Rivière, A
    Milleron, B
    Lemarie, E
    Trillet-Lenoir, V
    Soussan-Lazard, K
    Berille, J
    Douillard, JY
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (09) : 1107 - 1112
  • [43] Phase I study of carboplatin, irinotecan and docetaxel on a divided schedule with recombinant human granulocyte colony stimulating factor support in patients with stage IIIB or IV non-small cell lung cancer
    Fujita, A
    Ohkubo, T
    Hoshino, H
    Takabatake, H
    Tagaki, S
    Sekine, K
    ANTI-CANCER DRUGS, 2002, 13 (05) : 505 - 509
  • [44] Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer
    Pandya, Kishan J.
    Gajra, Ajeet
    Warsi, Ghulam M.
    Argonza-Aviles, Eliza
    Ericson, Solveig G.
    Wozniak, Antoinette J.
    LUNG CANCER, 2010, 67 (03) : 330 - 338
  • [45] Chemotherapy of stage IIIB and IV non-small-cell lung cancer
    Cojean, I
    LeChevalier, T
    ANNALS OF ONCOLOGY, 1995, 6 : 41 - 44
  • [46] Docetaxel versus docetaxel plus irinotecan as second line chemotherapy in advanced non-small cell lung cancer (NSCLC): A randomized phase II trial.
    Pectasides, D
    Farmakis, D
    Pectasides, M
    Kostopoulou, V
    Nikolaou, M
    Koumpou, M
    Gaglia, A
    Kountourakis, P
    Mylonakis, N
    Economopoulos, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 625S - 625S
  • [47] Phase I study of docetaxel in combination with Gemcitabine as first line chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC)
    Gatzemeier, U
    Bildat, S
    Harstrick, A
    Eberhardt, W
    Achterrath, W
    Krauss, C
    Wilke, HJ
    ANNALS OF ONCOLOGY, 1998, 9 : 93 - 93
  • [48] A phase IINCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer
    Molina, Julian R.
    Nikcevich, Daniel
    Hillman, Shauna
    Geyer, Susan
    Drevyanko, Timothy
    Jett, James
    Verdirame, Joseph
    Tazelaar, Henry
    Rowland, Kendrith
    Wos, Edward
    Kutteh, Leila
    Nair, Suresh
    Fitch, Tom
    Flynn, Patrick
    Stella, Philip
    Adjei, Alex A.
    CANCER INVESTIGATION, 2006, 24 (04) : 382 - 389
  • [49] Phase I-II study of gemcitabine and paclitaxel in pretreated patients with stage IIIB-IV non-small cell lung cancer
    Iaffaioli, RV
    Tortoriello, A
    Gravina, A
    Facchini, G
    Turitto, G
    Elia, S
    Griffo, S
    Gentile, M
    Fraioli, G
    Frattolillo, A
    Muto, P
    Libutti, M
    De Marino, V
    Illiano, A
    Barbarisi, A
    LUNG CANCER, 2000, 30 (03) : 203 - 210
  • [50] A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC)
    Ginopoulos, P
    Mastronikolis, NS
    Giannios, J
    Karana, A
    Siabi, V
    Karvelas, F
    Rathossis, S
    Apostolopoulos, N
    Mastorakou, A
    LUNG CANCER, 1999, 23 (01) : 31 - 37
12345